SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-20
👔
MapLight Therapeutics, Inc.
@MPLT_InsiderForm 4 Filing: GILLIS JONATHAN Sells $1.4M of $MPLT
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
MapLight Therapeutics, Inc.
Ticker: $MPLT
Transaction Value
$1.4M
Price/Share: $37.12
transaction date
2026-07-17
Shares: 36,979
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GILLIS JONATHAN, holds the title of CAO and Interim CFO at MapLight Therapeutics, Inc..
On 2026-07-17, the insider transacted 36,979 shares.The shares were transacted at a weighted average price of $37.12 per share, resulting in a total market-relevant value of $1.4M.
Executive Summary Summary
GILLIS JONATHAN (CAO and Interim CFO) sold $1.4M of $MPLT
Post-Transaction Position: 145,140 shares
SEC Accession No: 0001709954-26-000010 (CIK: 1709954)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.